About 40 percent of CVS Caremark clients saw negative specialty drug trends during the first three quarters of 2021, according to a report the pharmacy giant released Feb. 24.
Read the full post on Becker's Hospital Review - Healthcare News
40% of CVS Caremark’s PBM clients have a negative specialty drug trend
